PAYX vs SER · P/E 22, rev $6.51B vs $29.7M cap
Paychex Inc (PAYX) versus Serina Therapeutics Inc (SER) — a side-by-side from cached financials, not a winner call.
Paychex Inc (PAYX) is a software - application company listed on NASDAQ.
Serina Therapeutics Inc (SER) is a biotechnology company listed on AMEX.
Latest reported PAYX revenue for 2026-05-31 was $6.51B. Net income was $1.76B. Revenue was up 16.9% from 2025-05-31 to 2026-05-31. PAYX currently screens at market cap $34.96B and trailing P/E 21.5.
Latest reported SER revenue for 2026-06-30 was $0. Net income was -$13.3M. SER currently screens at market cap $29.7M.
PAYX currently screens at market cap $34.96B and trailing P/E 21.5. SER currently screens at market cap $29.7M.
Not investment advice. Open the PAYX and SER stock pages for the full models.
Not investment advice.